| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1950) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | H01AA01 |
| UNII: | K0U68Q2TXA |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Melanocortin receptor 2 agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Nephrotic Syndrome | 3 | D009404 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Multiple Sclerosis, Relapsing-Remitting | 3 | D020529 | ClinicalTrials |
| Kidney Diseases | 3 | D007674 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 3 | D005923 | ClinicalTrials |
| Epilepsy | 2 | D004827 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Migraine Disorders | 2 | D008881 | ClinicalTrials |
| Diabetic Nephropathies | 2 | D003928 | ClinicalTrials |
| Sarcoidosis | 2 | D012507 | ClinicalTrials |
| Uveitis | 2 | D014605 | ClinicalTrials |
| Dermatomyositis | 2 | D003882 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Scleritis | 2 | D015423 | ClinicalTrials |
| Renal Insufficiency, Chronic | 1 | D051436 | ClinicalTrials |
| Glomerulonephritis, Membranous | 1 | D015433 | ClinicalTrials |
| Polycystic Ovary Syndrome | 1 | D011085 | ClinicalTrials |
| Optic Neuritis | 1 | D009902 | ClinicalTrials |
| Glomerulonephritis | 1 | D005921 | ClinicalTrials |
| Vitreoretinopathy, Proliferative | 1 | D018630 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 12427-33-7 |
| ChEMBL | CHEMBL1201610 |
| FDA SRS | K0U68Q2TXA |
| PubChem | 16132265 |
CONTENTS